|
Volumn 12, Issue 7, 2010, Pages 469-471
|
Do diuretics diminish the predicted benefits on ischemic heart disease events of lowering blood pressure in hypertension?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
AMLODIPINE PLUS BENAZEPRIL;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE;
CALCIUM CHANNEL BLOCKING AGENT;
CHLORTALIDONE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LISINOPRIL;
THIAZIDE DIURETIC AGENT;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
DRUG EFFICACY;
EDITORIAL;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
HYPOKALEMIA;
ISCHEMIC HEART DISEASE;
KIDNEY DISEASE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RISK REDUCTION;
SUDDEN DEATH;
SYSTOLIC BLOOD PRESSURE;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CLINICAL TRIALS AS TOPIC;
DIURETICS;
HUMANS;
HYPERTENSION;
MYOCARDIAL ISCHEMIA;
SYSTOLE;
|
EID: 77955246417
PISSN: 15246175
EISSN: 17517176
Source Type: Journal
DOI: 10.1111/j.1751-7176.2010.00327.x Document Type: Editorial |
Times cited : (8)
|
References (8)
|